Reimbursement
Payments to insurance agents incentivize them to base referrals on financial considerations, DOJ says.
The drug company faces civil monetary penalties and the termination of its Pharmaceutical Pricing Agreement.
This is an 8% decline following the expiration of pandemic-era policies that temporarily increased star ratings for some plans.
Eighty hospitals want a reversal of a final rule that includes Medicare Advantage in payment calculations.
Compensation increased more than 5% for many specialties but only increased 3.6% among primary care specialties.
DOJ says St. Peter fraudulently submitted claims for services performed by an oncology doctor.
The action reverses a July 17 decision that Trinity would no longer accept UHC insurance at any of its practices and facilities.
The settlement claims NIRP illegally paid physicians for referrals to clinics established to surgically treat patients with PAD.
J&J alerted 340B hospitals that it will replace upfront discounts with rebates for Stelara and Xarelto.